Loading…
Underlying
Underlying Price
$38.90
Type
Put
Strike
35
Expiration
Nov 27, 2026
DTE
34d
Moneyness
OTM
Intrinsic
$0.00
NVO 35 Put Across Expirations
| Expiration | DTE | Last | Change | Vol | Open Int |
|---|---|---|---|---|---|
| Oct 23, 2026 | -1d | $0.01 | -66.67% | 1 | 1,040 |
| Oct 30, 2026 | 6d | $0.02 | +0.00% | 16 | 4,118 |
| Nov 6, 2026 | 13d | $0.20 | -16.67% | 223 | 645 |
| Nov 13, 2026 | 20d | $0.25 | -16.67% | 43 | 363 |
| Nov 20, 2026 | 27d | $0.27 | -18.18% | 113 | 37,138 |
| Nov 27, 2026 | 34d | $0.37 | -7.50% | 5 | 52 |
| Dec 18, 2026 | 55d | $0.51 | -15.00% | 201 | 14,779 |
| Jan 15, 2027 | 83d | $0.77 | -11.49% | 1,183 | 24,914 |
| Mar 19, 2027 | 146d | $1.48 | -5.73% | 40 | 19,132 |
| Jun 17, 2027 | 236d | $2.44 | -3.94% | 9 | 17,814 |
| Sep 17, 2027 | 328d | $3.05 | -4.39% | 4 | 1,837 |
| Dec 17, 2027 | 419d | $3.70 | -7.50% | 1 | 2,002 |
| Jan 21, 2028 | 454d | $3.77 | -1.31% | 19 | 9,304 |
| Jun 16, 2028 | 601d | $4.50 | -3.23% | 1 | 693 |
| Dec 15, 2028 | 783d | $5.87 | -4.55% | 7 | 1,013 |
| Jan 19, 2029 | 818d | $5.30 | -3.11% | 4 | 482 |
NVO Nearby Strikes · Nov 27, 2026
| Strike | Last | Change | Vol | Open Int | Moneyness |
|---|---|---|---|---|---|
| 29 P | $0.51 | +0.00% | 2 | 2 | OTM |
| 30 P | — | — | 0 | 0 | OTM |
| 31 P | $0.14 | +0.00% | 30 | 30 | OTM |
| 32 P | $0.09 | -64.00% | 6 | 17 | OTM |
| 33 P | $0.23 | -48.89% | 7 | 7 | OTM |
| 34 P | $0.20 | +122.22% | 2 | 11,406 | OTM |
| 35 P | $0.37 | -7.50% | 5 | 52 | OTM |
| 36 P | $0.54 | -8.47% | 182 | 182 | OTM |
| 37 P | $0.79 | -15.96% | 29 | 131 | OTM |
| 38 P | $1.02 | -15.70% | 40 | 51 | OTM |
| 39 P | $1.52 | -12.14% | 218 | 242 | ITM |
| 40 P | $2.05 | -9.69% | 28 | 163 | ITM |
| 41 P | $3.00 | -10.45% | 1 | 14 | ITM |
NVO Profile
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in nine countries and affiliates or offices in five countries.